Aldomet

Hypertension, Hypertensive disease, Therapeutic procedure

Treatment

1 FDA approval

20 Active Studies for Aldomet

What is Aldomet

Methyldopa

The Generic name of this drug

Treatment Summary

Methyldopa is a medication used to lower blood pressure. It works by blocking certain signals in the body that cause high blood pressure. Methyldopa was first introduced in 1960 and is usually taken as a pill or injection. It is most commonly used in pregnant women or those with kidney problems. Although there are newer, better-tolerated medications to treat high blood pressure, methyldopa is still used either by itself or in combination with other medications.

Aldoril

is the brand name

image of different drug pills on a surface

Aldomet Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Aldoril

Methyldopa

1962

32

Approved as Treatment by the FDA

Methyldopa, otherwise known as Aldoril, is approved by the FDA for 1 uses like Hypertensive disease .

Hypertensive disease

Helps manage High Blood Pressure (Hypertension)

Effectiveness

How Aldomet Affects Patients

Methyldopa works by decreasing the activity of the sympathetic nervous system, which helps to lower blood pressure. It can also reduce the levels of certain hormones and neurotransmitters in the body. When taken orally, it typically starts working within 12 to 24 hours and its effects typically peak within 4 to 6 hours. Once taken, the drug will remain in the body for 24 to 48 hours after it is stopped. When taken intravenously, the effects last for 10 to 16 hours.

How Aldomet works in the body

Methyldopa helps reduce blood pressure by working on two different pathways in the body. It stimulates alpha-2 adrenergic receptors in the brainstem, which reduces the amount of norepinephrine released in the area. This decreases the signals sent to the peripheral nervous system that produce constriction of blood vessels. Methyldopa also inhibits an enzyme called DOPA decarboxylase, which helps to deplete biogenic amines like norepinephrine. However, this effect only plays a minor role in the blood-pressure-lowering effect of methyldopa.

When to interrupt dosage

The suggested measure of Aldomet is based upon the ascertained affliction, including Therapeutic procedure, Hypertensive crisis and Hypertensive disease. The amount of dosage fluctuates as per the system of delivery (e.g. Intravenous or Tablet, film coated - Oral) specified in the accompanying table.

Condition

Dosage

Administration

Hypertension

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Hypertensive disease

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Therapeutic procedure

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Warnings

Aldomet has four contraindications, so it should not be consumed if any of the conditions in the ensuing table are present.

Aldomet Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

history of liver disorders caused by methyldopa

Do Not Combine

Liver Diseases

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Methyldopa may interact with Pulse Frequency

There are 20 known major drug interactions with Aldomet.

Common Aldomet Drug Interactions

Drug Name

Risk Level

Description

Amifostine

Major

Methyldopa may increase the hypotensive activities of Amifostine.

Iobenguane

Major

The therapeutic efficacy of Iobenguane can be decreased when used in combination with Methyldopa.

Abacavir

Minor

Methyldopa may decrease the excretion rate of Abacavir which could result in a higher serum level.

Aclidinium

Minor

Methyldopa may decrease the excretion rate of Aclidinium which could result in a higher serum level.

Acrivastine

Minor

Methyldopa may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Aldomet Toxicity & Overdose Risk

The smallest toxic amount of methyldopa taken orally is 44gm/kg/3Y for a female. In rats and mice, the lethal dose when taken orally is 5000mg/kg and 5300mg/kg respectively. When taken intraperitoneally, it is 300mg/kg in rats and 150mg/kg in mice. Overdosing on methyldopa can lead to low blood pressure, fatigue, weakness, slow heart rate, dizziness, lightheadedness, constipation, bloating, diarrhea, nausea, and vomiting. Treatment includes removing the drug from the body by inducing vomiting or gastric lav

image of a doctor in a lab doing drug, clinical research

Aldomet Novel Uses: Which Conditions Have a Clinical Trial Featuring Aldomet?

18 active studies are assessing the potential of Aldomet to provide therapeutic intervention, ameliorate Hypertensive disease and manage Hypertensive crises.

Condition

Clinical Trials

Trial Phases

Hypertension

0 Actively Recruiting

Therapeutic procedure

0 Actively Recruiting

Hypertensive disease

41 Actively Recruiting

Not Applicable, Phase 3, Phase 1, Phase 2

Aldomet Reviews: What are patients saying about Aldomet?

5

Patient Review

4/26/2010

Aldomet for High Blood Pressure

I've been taking aldomet for five years to manage my high blood pressure, and it's been working great. The only side effect I've noticed is that it makes me sleepy, which actually isn't a bad thing considering how much stress I'm under on a daily basis.

5

Patient Review

4/7/2010

Aldomet for High Blood Pressure

So far, this medication has been great for managing my pregnancy-induced hypertension. I was originally on Labetalol starting at 16 weeks, but the side effects were getting worse and I had to stop taking it. Aldomet 250mg twice a day has controlled my BP without any unwanted side effects.

4.7

Patient Review

6/20/2010

Aldomet for High Blood Pressure

Clonidine hadn't been working well for me in terms of keeping my blood pressure down, but as soon as I started taking Methlydopa things changed very quickly.

4.7

Patient Review

5/17/2008

Aldomet for High Blood Pressure

While this medication is very effective, it's also extremely dangerous. My mother took it for years and eventually died of pancreatic cancer as a result of the liver and digestive complications it caused. I would urge everyone to stay away from this drug.

3.7

Patient Review

7/6/2011

Aldomet for High Blood Pressure

Aldomet has been pretty effective in controlling my blood pressure, but the side effects are really tough to deal with. I'm hoping to find an alternative medication that won't be so debilitating.

3.7

Patient Review

6/22/2009

Aldomet for High Blood Pressure

I've been taking Aldomet for about 5 months. At first, I took 250mg once a day and it helped lower my blood pressure somewhat inconsistently. So then my doctor increased the dosage to 500mg twice a day. Now I'm constantly tired and dizzy, but my blood pressure is more consistent. Trying to conceive has been difficult while on this medication.

3.3

Patient Review

10/18/2009

Aldomet for High Blood Pressure

I switched to this drug over a year ago in preparation for conceiving. However, I had to add Procardia eventually to get my blood pressure under control. By the end of most days, I'm extremely tired and my legs are swollen.

3.3

Patient Review

5/20/2009

Aldomet for High Blood Pressure

I took aldomet while pregnant and had no side effects or problems. It worked very well for me.

3

Patient Review

5/30/2014

Aldomet for High Blood Pressure

While this medication does help to lower my blood pressure, I have been having some issues with my bladder. It feels like I need to go every ten minutes, which is really disruptive. This also happened when I tried taking Micardis without the water tablets. The doctor didn't believe me when I said it might be the medication, but I'm convinced that's what it is.

2.7

Patient Review

10/5/2010

Aldomet for High Blood Pressure

I've been on this medication for a while now, and it's not my favorite. My doctors prescribed it to me during pregnancy, and I'm still taking it 3 months after delivery. I don't like taking it while nursing, but the doctor says I don't have a choice.

2.3

Patient Review

7/16/2008

Aldomet for High Blood Pressure

Since being diagnosed with chronic hypertension 4 months ago, my blood pressure has been under control thanks to Aldomet (methyldopa). I haven't had any problems controlling my blood pressure since starting this medication, and it has helped me tremendously.

2.3

Patient Review

11/23/2013

Aldomet for High Blood Pressure

This medication helped to lower my blood pressure; however, I started experiencing anxiety and depression about a week after taking it. As a result, I am weaning myself off the medication.

1

Patient Review

2/3/2010

Aldomet for High Blood Pressure

Trying to conceive and extremely worried about the potential side effects of this medication. If anyone has any insight, please share!

1

Patient Review

3/4/2008

Aldomet for High Blood Pressure

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about aldomet

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Aldomet?

"There are some side effects to this medication, including dizziness, lightheadedness, drowsiness, headache, and a stuffy nose. These effects are more likely to occur when starting the medication or when the dosage is increased."

Answered by AI

Why is Aldomet used in pregnancy?

"Methyldopa is a medication used to lower blood pressure in pregnancy."

Answered by AI

What is the best time to take Aldomet?

"To use Aldomet Tablet, take it orally with or without food as directed by your doctor, typically 2 to 4 times daily. Start taking this medication or any new dose increase in the evening to lower the risk of side effects. Also, if the doses of this medication are not equal, take the larger dose at bedtime."

Answered by AI

What is Aldomet drug used for?

"Aldomet contains methyldopa, an active substance that belongs to a group of medicines called 'antihypertensives.' Methyldopa is changed inside your body to a natural substance that lowers blood pressure. Your doctor has prescribed Aldomet to treat high blood pressure (hypertension)."

Answered by AI

Clinical Trials for Aldomet

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Barber and Pharmacist Coordination for High Blood Pressure

35 - 79
Male
Los Angeles, CA

The original, "Cut Your Pressure Too: The LA Barbershop Blood Pressure Study (LABBPS)" (NCT02321618) was a highly successful cluster-randomized trial of a community centered blood pressure (BP) reduction program focused on Non-Hispanic (NH) black men who experience the highest rates of hypertension (HTN) and its complications. Patrons of 52 barbershops in Los Angeles County were randomly assigned to either an intervention arm in which barbers encouraged meetings with trained clinical pharmacists who provided HTN treatment in the barbershops or a control arm in which barbers provided educational pamphlets on HTN and encouraged physician appointments. After 6 months, the intervention group had a statistically significant reduction in systolic BP (SBP) of 21.6 mmHg compared to the control group. Results were durable at 1 year. Thereafter, a pilot study (NCT03726710) aimed at improving the efficiency of the barbershop model of HTN care by substituting in-person visits with video visits once BP was at goal was undertaken in 10 hypertensive barbershop patrons. The intervention effect was unchanged. The current study represents Aim 3 of an NIH funded renewal application entitled, "Barber and Pharmacist Coordination to Improve Blood Pressure Management in Black Men." It will build upon the foundational work of the original study and telemedicine pilot by evaluating the efficacy of a fully remote hypertension management program.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Christine Albert, MD, MPH

Image of Foothills Medical Center in Calgary, Canada.

Spinal Cord Stimulation for High Blood Pressure

18+
All Sexes
Calgary, Canada

High blood pressure, also called hypertension, raises the risk of heart disease, stroke, and kidney disease. Medications work well for many people, but some people still have blood pressure that stays too high, or they have side effects from their medications. Researchers are looking for treatments that do not involve taking more medication. Nerves help control blood pressure by changing how blood vessels tighten and how hard the heart pumps. Because of this, treatments that act on nerves may be able to lower blood pressure. Spinal cord stimulation is a treatment already used to manage long-term pain. It uses a small device, placed under the skin during a standard operation, that sends mild electrical signals to the spine. Laboratory studies suggest that stimulating the lower part of the mid-back may also lower blood pressure, but this has not been carefully studied in people who already use these devices. This study will look at whether changing the settings on a spinal cord stimulator affects blood pressure. About 11 adults who have high blood pressure and who already have a spinal cord stimulator for long-term pain. No new device will be placed, and no surgery or other invasive procedure will be done for this study. Participants attend a series of study visits. At each visit, trained staff record blood pressure and heart rate while the stimulator is turned on, turned off, and set to other settings that the person's care team has approved and that the person finds comfortable. There are rest breaks between each setting. Over successive visits, the study team works to identify the settings that best lower blood pressure. Participants can stop at any time, and their usual settings are restored at the end of each visit. The study will also look at whether this kind of testing is practical and comfortable for participants. The results will help researchers decide whether larger studies of spinal cord stimulation for blood pressure control are worth doing.

Waitlist Available
Has No Placebo

Foothills Medical Center

Aaron Phillips, PhD

Image of Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington in Arlington, United States.

Alcohol Abstinence for High Blood Pressure

26 - 49
All Sexes
Arlington, TX

The purpose of this study is to learn whether avoiding alcohol can improve heart and blood vessel health in adults who regularly drink alcohol and have high blood pressure. High blood pressure is a major risk factor for cardiovascular disease (CVD), including heart attack and stroke. In this randomized, controlled trial, men and women aged 26 to 49 years who regularly consume alcohol and have high blood pressure will be assigned by chance to either stop drinking alcohol or continue their usual drinking habits for 8 weeks. Researchers will compare changes in blood pressure and other cardiovascular disease risk factors between the two groups. The information gained from this study may help researchers and health care providers better understand the effects of alcohol consumption on cardiovascular health and whether alcohol abstinence can reduce heart disease risk, especially in adults with high blood pressure.

Recruiting
Has No Placebo

Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington

Image of Department of Family & Community Medicine; University of Alabama at Birmingham in Birmingham, United States.

Treatment for High Blood Pressure

18+
All Sexes
Birmingham, AL

The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.

Waitlist Available
Has No Placebo

Department of Family & Community Medicine; University of Alabama at Birmingham

Have you considered Aldomet clinical trials?

We made a collection of clinical trials featuring Aldomet, we think they might fit your search criteria.
Go to Trials
Image of NeuroFit Lab, Ivor Wynne Centre, McMaster University in Hamilton, Canada.

Isometric Handgrip Exercise for High Blood Pressure

65+
All Sexes
Hamilton, Canada

The goal of this clinical trial is to evaluate whether a short, supervised isometric handgrip exercise program is feasible and acceptable for older adults with elevated blood pressure or hypertension. It will also explore whether this type of exercise may improve blood pressure and cognitive function. The main questions it aims to answer are: * Is this handgrip exercise program practical and acceptable for older adults to participate in within a community exercise setting? * Does participation in the program lead to changes in blood pressure and cognitive function? Researchers will compare two handgrip devices to determine whether the method of delivering the exercise influences feasibility and outcomes. Participants will: * Be randomly assigned to use one of two handgrip devices. * Complete supervised exercise sessions twice per week for 4 weeks. * Perform brief handgrip contractions at a set intensity during each session. * Complete blood pressure and cognitive assessments before and after the program.

Recruiting
Has No Placebo

NeuroFit Lab, Ivor Wynne Centre, McMaster University (+1 Sites)

Jennifer Heisz, PhD

Image of Vanderbilt University Medical Center in Nashville, United States.

2-HOBA for Salt Sensitivity of Blood Pressure

18+
All Sexes
Nashville, TN

Hypertension is the leading cause of preventable deaths globally, driven by complications such as myocardial infarction, stroke, heart failure, and kidney disease. Recent updates in hypertension classification by the American Heart Association (AHA) place nearly half of the U.S. population in the hypertensive category. Excess dietary salt is a major risk factor for hypertension, with 50% of hypertensive individuals exhibiting salt-sensitivity of blood pressure (SSBP). SSBP is an independent predictor of cardiovascular events and death. While kidney mechanisms in salt-sensing have been extensively studied, emerging evidence suggests that immune cells can also sense sodium (Na+). This trial hypothesizes that myeloid cell-derived isolevuglandins (IsoLGs) drive endothelial dysfunction, perpetuating the salt-sensitive phenotype. Preliminary data indicate that targeting IsoLGs with the IsoLG scavenger 2-hydroxybenzylamine (2-HOBA) may interrupt this immune-vascular axis, reducing salt sensitivity and associated cardiovascular risks. This phase 2 clinical trial aims to investigate the role of 2-HOBA in modulating immune cell function within blood vessels in hypertensive patients. The study will explore the impact of immunity on salt sensitivity and assess 2-HOBA's potential to reduce endothelial dysfunction, improve immune cell activation, and alleviate SSBP.

Phase 2
Waitlist Available

Vanderbilt University Medical Center

Image of UPMC Magee Womens Hospital in Pittsburgh, United States.

Mobile Health Program for High Blood Pressure After Preeclampsia

18+
Female
Pittsburgh, PA

Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.

Recruiting
Has No Placebo

UPMC Magee Womens Hospital

Malamo Countouris, MD, MS

Have you considered Aldomet clinical trials?

We made a collection of clinical trials featuring Aldomet, we think they might fit your search criteria.
Go to Trials
Image of Hāmākua-Kohala Health Center in Honokaa, United States.

Produce Prescription for High Blood Pressure

18+
All Sexes
Honokaa, HI

This multi-site randomized controlled trial uses a community-based approach to evaluate a Food as Medicine program for Native Hawaiian and Pacific Islander (NHPI) adults in Hawaii who have high blood pressure and difficulty affording healthy food. The study has two main goals: (1) to implement a produce prescription program and see if adding personal support from Community Health Workers (CHW) improves blood pressure among other health outcomes, and (2) to determine the program's cost-effectiveness. The study will take place across three Federally Qualified Health Centers in Hawaii. Produce prescription program participants at each site will receive $100 per month, either in the form of produce boxes or monthly vouchers to purchase fruits and vegetables, for 12 months (totaling $1200). In past studies, personal challenges (e.g., lack of transportation, lack of cooking skills) have made it difficult for participants to use the vouchers and/or the purchased produce. In other food as medicine interventions, participants have similarly faced various personal, social, and environmental barriers that limit the program's efficacy. To help participants navigate through these challenges, the investigators want to test adding 1-on-1 support from a CHW throughout the program. Other studies have found that health interventions delivered by CHWs have been effective in reducing blood pressure, blood glucose and weight, especially among vulnerable populations, such as NHPIs and those with food insecurity. The CHWs in this study will receive a training using a curriculum tailored specifically to their community and that is in alignment with the Pilinahā: The Four Connections Framework, which focuses on key connections that Indigenous people seek to attain health and can be employed to overcome health disparities. To test the effectiveness of the added CHW support, there will be two groups of participants: Group 1 (Intervention) will receive the monthly produce prescription ($100 vouchers or produce box) plus meet with a CHW every two months for support with program challenges. Group 2 (Control) will receive the same monthly produce prescription, but will not have meetings with a CHW. The investigators want to see if the added support from CHWs leads to better blood pressure results, among other health outcomes. Upon providing informed consent and enrolling into the program, produce prescription program participants will: * Attend 5 study visits over the one year program. These happen at the start, and then at 3, 6, 9, and 12 months. * Complete health checks at the first visit. This includes getting a home blood pressure monitor and learning about heart health and nutrition. Staff will measure height, weight, waist size, and blood pressure. * Answer surveys about their demographic background, health habits, diet, and culture. * Receive $100 in vouchers every month for 12 months to redeem for fruits and vegetables at a local retailer. * Group 1 will additionally meet with a CHW every two months for 1-on-1 support with any challenges related to the program. * Group 2 will receive monthly reminders to use their vouchers but no CHW meetings. After the program ends, researchers will analyze the financial value of the intervention. This involves calculating the total cost to run the program (including vouchers, CHW training and salaries, and administrative costs) and comparing it to potential savings in healthcare costs. By looking at improvements in blood pressure, researchers can estimate how many heart-related health problems were prevented and how much money was saved on medical care.

Waitlist Available
Has No Placebo

Hāmākua-Kohala Health Center (+2 Sites)

Have you considered Aldomet clinical trials?

We made a collection of clinical trials featuring Aldomet, we think they might fit your search criteria.
Go to Trials